Zura Bio Initiated at Overweight by Piper Sandler
Zura Bio Initiated at Overweight by Piper Sandler
Dow JonesMay 3 05:46 ET
Express News | Piper Sandler Initiates Coverage On Zura Bio With Overweight Rating, Announces Price Target of $26
BenzingaMay 3 05:36 ET
Analysts Are Bullish on These Healthcare Stocks: Irhythm Technologies (IRTC), Zura Bio (ZURA)
TipRanksMay 3 05:25 ET
Express News | Venrock Healthcare Capital Partners III,L.p. Reports Passive Stake of 9.99% in Zura Bio Ltd as of April 22, 2024
ReutersMay 2 17:13 ET
Behind The Uptrend: Understanding Zura Bio (ZURA) Stock Surge
The shares of Zura Bio Limited (NASDAQ: ZURA) are currently witnessing a remarkable surge, demonstrating a significant increase of 20.17% during the current trading session, reaching a value of $4.35. This substantial uptrend in the price of ZUR stock follows recent equity actions, as there is no immediate discernible catalyst directly responsible for this surge. ...
Stocks TelegraphApr 26 14:20 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 61.4% to $1.17 during Friday's regular session. The company's market cap stands at $5.1 million. Agenus (NASDAQ:AGEN) shares rose 32.53% to $11.
BenzingaApr 26 12:31 ET
Zura Bio Insider Bought Shares Worth $3,715,000, According to a Recent SEC Filing
Someit Sidhu, Director, on April 22, 2024, executed a purchase for 1,186,901 shares in Zura Bio (ZURA) for $3,715,000. Following the Form 4 filing with the SEC, Sidhu has control over a total of 3,675
MT NewswiresApr 25 09:57 ET
Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)
Yahoo FinanceApr 25 02:18 ET
Zura Bio Raises $112.5M Through Private Placement Deal
TipRanksApr 23 06:13 ET
Express News | Zura Bio Shares Are Trading Higher. The Company Announced an Oversubscribed $112.5 Million Private Placement
Moomoo 24/7Apr 18 12:36 ET
Express News | Zura Bio Ltd: Agreed to Sell an Aggregate of Approximately 20.1 Mln Class a Ordinary Shares at a Purchase Price of $3.108 per Share
Moomoo 24/7Apr 18 09:23 ET
Express News | Zura Bio Ltd: Strengthened Balance Sheet Expected to Fund Operations Through 2027
Moomoo 24/7Apr 18 09:22 ET
Express News | Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Moomoo 24/7Apr 18 09:22 ET
Zura Bio Issues Key Update for Investors
TipRanksApr 8 06:22 ET
Express News | Zura Bio Announces That Robert Lisicki Has Assumed The Role Of Chief Executive Officer And A Director
Moomoo 24/7Apr 8 06:11 ET
Insider Buyers At Zura Bio Recover Some Losses, But Still Down US$165k
Yahoo FinanceApr 2 06:22 ET
Oppenheimer Reiterates Outperform on Zura Bio, Lowers Price Target to $16
Oppenheimer analyst Jeff Jones reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.
BenzingaApr 1 09:33 ET
Zura Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 540% Oppenheimer $17 → $16 Reiterates Outperform → Outperform 10/10/2023 300% Ladenburg Thalman
BenzingaApr 1 09:32 ET
Zura Bio Ltd (ZURA) Reports Full Year 2023 Financial Results Amidst Leadership Transition
Yahoo FinanceMar 31 21:01 ET
Zura Bio GAAP EPS of -$2.09
Seeking AlphaMar 28 08:53 ET
No Data
No Data